Dr. Jeffrey R. Jay, M.D
Latest statistics and disclosures from Jay Jeffrey R's latest quarterly 13F-HR filing:
- Top 5 stock holdings are Hyperion Therapeutics, Furiex Pharmaceuticals, D Stemline Therapeutics, Biodel, Ambit Bioscience, and represent 52.93% of Jay Jeffrey R's stock portfolio.
- Added to shares of these 10 stocks: Hyperion Therapeutics (+$21M), Furiex Pharmaceuticals (+$17M), D Stemline Therapeutics (+$14M), Biodel (+$7.7M), Ambit Bioscience (+$7.0M), GERN (+$5.6M), Pain Therapeutics (+$5.1M), Sunshine Heart (+$5.1M), Durata Therapeutics, Nordion.
- Started 31 new stock positions in Durata Therapeutics, Mast Therapeutics, RTI Biologics, Biodel, OncoGenex Pharmaceuticals, Trinity Biotech, Sunshine Heart, Nordion, XenoPort, D Horizon Pharma.
- Reduced shares in these 10 stocks: Hyperion Therapeutics (-$23M), Furiex Pharmaceuticals (-$18M), VNDA (-$8.4M), OncoGenex Pharmaceuticals (-$6.9M), Pain Therapeutics (-$5.8M), Acelrx Pharmaceuticals, D Horizon Pharma, Biodel, D Stemline Therapeutics, Targacept.
- Sold out of its positions in AMAG Pharmaceuticals, Acelrx Pharmaceuticals, AVEO Pharmaceuticals, Biodel, Cardiovascular Systems, EXAS, Furiex Pharmaceuticals, D Horizon Pharma, Hyperion Therapeutics, Mei Pharma. MYGN, NEO, OncoGenex Pharmaceuticals, Oncothyreon, Pain Therapeutics, RTI Biologics, D Stemline Therapeutics, Targacept, VNDA, Wright Med Group Inc right 03/01/2019, ZIOPHARM Oncology.
- Jay Jeffrey R was a net buyer of stock by $33M.
- Jay Jeffrey R has $127M in assets under management (AUM), dropping by 35.60%.
- Central Index Key (CIK): 0001239607
Portfolio Holdings for Jay Jeffrey R
Jay Jeffrey R holds 32 positions in its portfolio as reported in the June 2013 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Hyperion Therapeutics | 16.8 | $21M | NEW | 964k | 22.00 |
|
| Furiex Pharmaceuticals | 13.3 | $17M | NEW | 494k | 34.07 |
|
| D Stemline Therapeutics | 11.2 | $14M | NEW | 596k | 23.84 |
|
| Biodel | 6.1 | $7.7M | NEW | 1.9M | 4.18 |
|
| Ambit Bioscience | 5.5 | $7.0M | NEW | 1.0M | 7.00 |
|
| Geron Corporation (GERN) | 4.4 | $5.6M | NEW | 3.8M | 1.50 |
|
| Pain Therapeutics | 4.1 | $5.1M | NEW | 2.3M | 2.21 |
|
| Sunshine Heart | 4.0 | $5.1M | NEW | 950k | 5.37 |
|
| Durata Therapeutics | 3.6 | $4.6M | NEW | 639k | 7.20 |
|
| Nordion | 3.1 | $4.0M | NEW | 538k | 7.40 |
|
| D Horizon Pharma | 3.1 | $3.9M | NEW | 1.6M | 2.46 |
|
| OncoGenex Pharmaceuticals | 2.7 | $3.4M | NEW | 347k | 9.80 |
|
| Impax Laboratories | 2.4 | $3.0M | NEW | 150k | 19.94 |
|
| Trinity Biotech | 2.2 | $2.7M | NEW | 163k | 16.85 |
|
| RTI Biologics | 2.0 | $2.5M | NEW | 674k | 3.76 |
|
| Dyax | 2.0 | $2.5M | NEW | 728k | 3.46 |
|
| Mast Therapeutics | 2.0 | $2.5M | NEW | 5.8M | 0.43 |
|
| Protalix BioTherapeutics | 1.6 | $2.0M | NEW | 399k | 4.91 |
|
| Myriad Genetics (MYGN) | 1.5 | $1.9M | NEW | 70k | 26.87 |
|
| Volcano Corporation | 1.4 | $1.8M | NEW | 100k | 18.13 |
|
| Targacept | 1.2 | $1.6M | NEW | 368k | 4.27 |
|
| AVANIR Pharmaceuticals | 0.9 | $1.2M | NEW | 259k | 4.60 |
|
| XenoPort | 0.9 | $1.2M | NEW | 233k | 4.95 |
|
| Mei Pharma | 0.9 | $1.1M | NEW | 158k | 7.13 |
|
| Pernix Therapeutics Holdings | 0.8 | $1.1M | NEW | 297k | 3.61 |
|
| Palatin Technologies | 0.8 | $1.1M | -14% | 1.7M | 0.62 |
|
| Vascular Solutions | 0.5 | $680k | NEW | 46k | 14.72 |
|
| Wright Med Group Inc right 03/01/2019 | 0.4 | $542k | NEW | 200k | 2.71 |
|
| Celsion Corporation | 0.1 | $190k | NEW | 186k | 1.02 |
|
| CryoLife (AORT) | 0.1 | $164k | NEW | 26k | 6.25 |
|
| Gw Pharmaceuticals Plc ads | 0.1 | $102k | NEW | 12k | 8.78 |
|
| AMAG Pharmaceuticals | 0.0 | $3.0k | NEW | 150.00 | 20.00 |
|
Past Filings by Jay Jeffrey R
SEC 13F filings are viewable for Jay Jeffrey R going back to 2011
- Jay Jeffrey R 2013 Q2 filed Aug. 14, 2013
- Dr. Jeffrey R. Jay, M.D. 2013 Q1 filed May 15, 2013
- Dr. Jeffrey R. Jay, M.D. 2012 Q4 filed Feb. 14, 2013
- Dr. Jeffrey R. Jay, M.D. 2012 Q3 filed Nov. 14, 2012
- Dr. Jeffrey R. Jay, M.D. 2012 Q2 filed Aug. 14, 2012
- Dr. Jeffrey R. Jay, M.D. 2012 Q1 filed May 14, 2012
- Dr. Jeffrey R. Jay, M.D. 2011 Q4 filed Feb. 14, 2012
- Dr. Jeffrey R. Jay, M.D 2011 Q3 filed Nov. 14, 2011
- Dr. Jeffrey R. Jay, M.D 2011 Q1 filed May 16, 2011